Barclays analyst Stephanie Davis raised the firm’s price target on LifeStance (LFST) to $7 from $6 and keeps an Underweight rating on the shares. The company reported a “strong” Q3, primarily on rates upside in both magnitude and timing, but this pull forward will optically weigh on fiscal 2025, with margins expected to be flat, the analyst tells investors in a research note.
Maximize Your Portfolio with Data Driven Insights:
- Leverage the power of TipRanks' Smart Score, a data-driven tool to help you uncover top performing stocks and make informed investment decisions.
- Monitor your stock picks and compare them to top Wall Street Analysts' recommendations with Your Smart Portfolio
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on LFST: